FGFR3 and urinary bladder carcinoma: In a recent bladder cancer study FGFR3 mutation in combination with APC, RASSF1A, and SFRP2 methylation markers provided a sensitivity of 90% using tissue samples and 62% using paired urine samples to identify the presence of cancer with 100% specificity [1].